Internal Medicine, Endocrinology, Diabetes, & Metabolism · San Jose, CA
NPI
1053569228
Since 2008
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
751 S Bascom Ave, Valley Specialty Center, Suite 210
San Jose, CA, 95128
Phone (408) 793-2515
Groups this clinician bills Medicare through
Medicare paid, 2024
$36K
561 services
Medicare patients, 2024
187
Average age 71
Drug cost, 2024
$1.0M
1,537 prescriptions
Company payments
-
None reported
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Patricia M Salmon was code 99213 (office e&m - established), 231 times for 99 patients. In total Patricia M Salmon billed 561 services in 14 codes, and Medicare paid $36K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2013-10-29.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Facility | 231 | 99 | $53.27 | $12K |
| 99214 Office E&M - Established | Facility | 220 | 82 | $80.39 | $18K |
| 99231 Hospital E&M - Subsequent | Facility | 29 | 13 | $42.63 | $1,236 |
| 99203 Office E&M - New | Facility | 20 | 20 | $58.37 | $1,167 |
| 99204 Office E&M - New | Facility | 12 | 12 | $109.76 | $1,317 |
By year: 2022 $25K for 418 services; 2023 $29K for 476 services; 2024 $36K for 561 services.
Medicare prescription drug claims, 2024
In 2024, the drug Patricia M Salmon prescribed most often to Medicare patients was Levothyroxine Sodium, with 162 prescriptions and refills. In total Patricia M Salmon wrote 1,537 Medicare prescriptions that cost $1.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 162 | 437 | 45 | $1,521 |
| Ozempic Semaglutide | 138 | 173 | 26 | $151K |
| Metformin Hcl Generic | 93 | 219 | 29 | $594 |
| Jardiance Empagliflozin | 71 | 149 | 21 | $78K |
| Methimazole Generic | 70 | 205 | 27 | $885 |
| Trulicity Dulaglutide | 58 | 66 | 11 | $61K |
| Hydrocortisone Generic | 50 | 132 | 15 | $2,267 |
| Ultra-Fine Short Pen Needle Pen Needle, Diabetic | 44 | 98 | 16 | $5,762 |
| Prolia Denosumab | 44 | 264 | 28 | $66K |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 41 | 76 | 14 | $3,207 |
| Semglee (Yfgn) Pen Insulin Glargine-Yfgn | 39 | 88 | 14 | $19K |
| Alendronate Sodium Generic | 34 | 95 | 11 | $208 |
| Evenity (2 Syringes) Romosozumab-Aqqg | 33 | 33 | Under 11 | $74K |
| Glipizide Generic | 30 | 75 | 13 | $463 |
| Basaglar Kwikpen U-100 Insulin Glargine,hum.Rec.Anlog | 30 | 67 | 14 | $11K |
Brand drugs: 849 claims; generic drugs: 556 claims.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Patricia M Salmon were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.